23 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Digirad, Inc. DRAD shares increased by 77.7% to $5.67 during Friday's pre-market session.
• Neuronetics, Inc. STIM shares increased by 23.6% to $3.35.
• Aethlon Medical, Inc. AEMD shares moved upwards by 18.4% to $2.64.
• OPKO Health, Inc. OPK shares increased by 15.1% to $2.37.
• T2 Biosystems, Inc. TTOO shares increased by 10.7% to $0.57.
• Dynatronics, Inc. DYNT shares moved upwards by 8.5% to $2.67.
• ObsEva, Inc. OBSV stock moved upwards by 8.5% to $3.06. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $40.00.
• Heat Biologics, Inc. HTBX shares moved upwards by 8.2% to $1.05. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.
• Novavax, Inc. NVAX stock rose 6.5% to $13.71. The most recent rating by B. Riley FBR, on February 28, is at Buy, with a price target of $16.00.
• Sorrento Therapeutics, Inc. SRNE shares moved upwards by 6.0% to $2.46.
• Cocrystal Pharma, Inc. COCP shares rose 5.3% to $1.20.
• Novan, Inc. NOVN shares rose 4.9% to $0.36. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
• GenMark Diagnostics, Inc. GNMK stock increased by 4.6% to $5.89. The most recent rating by Needham, on March 03, is at Buy, with a price target of $11.00.
• Allied Healthcare Prods, Inc. AHPI stock surged 3.5% to $19.15.

Losers

• Bionano Genomics, Inc. BNGO stock fell 21.2% to $0.89 during Friday's pre-market session.
• Beyond Air, Inc. XAIR shares fell 9.8% to $8.40.
• Biocept, Inc. BIOC shares plummeted 7.4% to $0.47.
• Tilray, Inc. TLRY stock decreased by 7.1% to $10.40. According to the most recent rating by Eight Capital, on March 03, the current rating is at Neutral.
• Ritter Pharmaceuticals, Inc. RTTR stock plummeted 6.8% to $0.48.
• Cellectis, Inc. CLLS stock fell 5.5% to $14.87. The most recent rating by BTIG Research, on February 19, is at Buy, with a price target of $39.00.
• Schrodinger, Inc. SDGR stock plummeted 4.8% to $39.21.
• Zosano Pharma, Inc. ZSAN stock decreased by 3.9% to $0.74.
• Teva Pharmaceutical Indus, Inc. TEVA stock plummeted 3.9% to $10.54. The most recent rating by Wells Fargo, on March 05, is at Equal-Weight, with a price target of $12.00.